ESPEN guideline on clinical nutrition in the intensive care unit.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
02 2019
Historique:
received: 28 08 2018
accepted: 29 08 2018
pubmed: 24 10 2018
medline: 24 3 2020
entrez: 24 10 2018
Statut: ppublish

Résumé

Following the new ESPEN Standard Operating Procedures, the previous guidelines to provide best medical nutritional therapy to critically ill patients have been updated. These guidelines define who are the patients at risk, how to assess nutritional status of an ICU patient, how to define the amount of energy to provide, the route to choose and how to adapt according to various clinical conditions. When to start and how to progress in the administration of adequate provision of nutrients is also described. The best determination of amount and nature of carbohydrates, fat and protein are suggested. Special attention is given to glutamine and omega-3 fatty acids. Particular conditions frequently observed in intensive care such as patients with dysphagia, frail patients, multiple trauma patients, abdominal surgery, sepsis, and obesity are discussed to guide the practitioner toward the best evidence based therapy. Monitoring of this nutritional therapy is discussed in a separate document.

Identifiants

pubmed: 30348463
pii: S0261-5614(18)32432-4
doi: 10.1016/j.clnu.2018.08.037
pii:
doi:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

48-79

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2018 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Pierre Singer (P)

Department of General Intensive Care and Institute for Nutrition Research, Rabin Medical Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel. Electronic address: psinger@clalit.org.il.

Annika Reintam Blaser (AR)

Department of Anaesthesiology and Intensive Care, University of Tartu, Tartu, Estonia; Department of Intensive Care Medicine, Lucerne Cantonal Hospital, Lucerne, Switzerland.

Mette M Berger (MM)

Service of Adult Intensive Care and Burns, Lausanne University Hospital, Lausanne, Switzerland.

Waleed Alhazzani (W)

Department of Medicine, Division of Critical Care and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.

Philip C Calder (PC)

Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Michael P Casaer (MP)

Clinical Department and Laboratory of Intensive Care Medicine, Catholic University Hospitals (UZLeuven) and Catholic University Leuven, Leuven, Belgium.

Michael Hiesmayr (M)

Division Cardiac-, Thoracic-, Vascular Anaesthesia and Intensive Care, Medical University Vienna, Vienna, Austria.

Konstantin Mayer (K)

Universitätsklinikum Gießen Medizinische, Gießen, Germany.

Juan Carlos Montejo (JC)

Servicio de Medecina Intensiva, Hospital Universitario 12 de Octobre, Madrid, Spain.

Claude Pichard (C)

Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland.

Jean-Charles Preiser (JC)

Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.

Arthur R H van Zanten (ARH)

Department of Intensive Care, Gelderse Vallei Hospital, Ede, the Netherlands.

Simon Oczkowski (S)

Department of Medicine, Division of Critical Care and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Canada.

Wojciech Szczeklik (W)

Department of Intensive Care and Perioperative Medicine, Jagiellonian University Medical College, Krakow, Poland.

Stephan C Bischoff (SC)

Department of Nutritional Medicine/Prevention, University of Hohenheim, Stuttgart, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH